21 Facts About Mark McClellan

Mark Barr McClellan was born on June 26,1963 and is the director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business, Medicine and Health Policy at Duke University.

Formerly, he was a senior fellow and director of the Health Care Innovation and Value Initiative at the Engelberg Center for Health Care Reform at The Brookings Institution, in Washington, DC McClellan served as commissioner of the United States Food and Drug Administration under President George W Bush from 2002 through 2004, and subsequently as administrator of the Centers for Medicare and Medicaid Services from 2004 through 2006.

Mark McClellan earned a Master of Public Administration degree from Harvard Kennedy School in 1991.

Mark McClellan completed his residency training in internal medicine at Brigham and Women's Hospital, and he is board-certified in internal medicine.

Mark McClellan has twice received the Arrow Award for Outstanding Research in Health Economics.

From 1998 to 1999, Mark McClellan served as deputy assistant secretary of the Treasury for Economic Policy, where he supervised economic analysis and policy development on a wide range of domestic policy issues.

Mark McClellan was a member of the president's Council of Economic Advisers, where he advised on domestic economic issues.

Mark McClellan served during this time as a senior policy director for health care and related economic issues for the White House.

Mark McClellan served as commissioner for the Food and Drug Administration beginning November 14,2002, becoming the first economist to hold that position.

Mark McClellan was administrator for the Centers for Medicare and Medicaid Services in the United States Department of Health and Human Services from 2004 to 2006.

On September 5,2006, Mark McClellan announced his resignation from his post in the department.

Mark McClellan told The Associated Press he would be leaving the agency in about five weeks and would probably work for a think tank where he could write about improving health care in the United States.

Mark McClellan is the founding chair and senior advisor of the Reagan-Udall Foundation, a public-private partnership between the US Food and Drug Administration and industry founded in 2007.

Previously, Mark McClellan was associate professor of economics at Stanford University, associate professor of medicine at the Stanford University School of Medicine, a practicing internist, and director of the Program on Health Outcomes Research at Stanford University.

Mark McClellan was a research associate of the National Bureau of Economic Research and a visiting scholar at the American Enterprise Institute.

Mark McClellan's model allows individual aspects of PPS to be evaluated for their contribution to cost sharing rates and reimbursement variance.

Mark McClellan used linear regression to approximate how the cost sharing reimbursement is derived, using fixed and variable components.

Mark McClellan's review serves as a harbinger of current attempts to model a health care reimbursement program focused on pay for performance criteria such as penalties for readmissions and incentives for value-based purchasing.

Mark McClellan later said he did not know if anyone outside FDA influenced the decision.

Mark McClellan said in his deposition that he was not involved in the decision to reject the initial Plan B application for non-prescription sales; he left the FDA in February 2004 to head the agency that runs Medicare and Medicaid.

Mark McClellan said that he was never told by anyone higher up in the Bush administration what to do about the application, although he did say that he "briefed" two White House domestic-policy advisors.